Florida / New York | ADVERTISE

A Publication for the Practising Medical Specialist, Industry Executive & Investor

Medical Device News Magazine is a digital Publication Founded in 2008, and proudly located in the United States

Medical Device News Magazine delivers the latest updates from the medical device and biotechnology sectors. We take pride in offering high-quality, in-depth content, crafted by a team of experienced professionals. Our goal is to provide a unique perspective on the trends and innovations driving the future of medical technology. By reading our articles, you’re not only gaining exclusive industry insights but also becoming part of a community committed to advancing healthcare through groundbreaking technologies. Explore our content and consider partnering with us for advertising opportunities!

“Medical Device News: Essential Key Insights and Noteworthy Developments Shaping the Future”

Terumo Neuro Celebrates 15 Years of the WEB Device: A Game-Changing Innovation in Aneurysm Treatment

Carsten Schroeder, President and CEO of Terumo Neuro, commented on this significant milestone: “The WEB device has set a new standard in aneurysm treatment and has been instrumental in our mission to drive game-changing impact in neurovascular care. With 15 years of proven clinical success, WEB continues to advance patient outcomes, reducing the need for multiple devices and lengthy procedures. As we celebrate this achievement, we remain committed to innovating alongside leading physicians worldwide to shape the future of neurovascular care.”

Paragonix Technologies Secures Official EU MDR Approval for 5 Organ Preservation Devices

Dr. Lisa Anderson, President of Paragonix Technologies. “This achievement validates our technology’s safety and effectiveness while expanding our ability to serve patients and healthcare providers in critical transplant care across the world. With this approval and the support structure provided by Sweden-based Getinge, we are dedicated to setting new standards in organ preservation, advancing the future of transplantation, and making a global impact.”

Clinical Trials

Study Highlights How C2N’s PrecivityAD2™ Blood Biomarker Test Use Improves Clinical Decision-Making in the Evaluation for Alzheimer’s Disease

Dr. Joel Braunstein, CEO of C2N Diagnostics, says, “This research increases the growing body of evidence that demonstrates high clinical utility with blood biomarkers, which is bringing important advancements to the field. Too often, patients face a complex and delayed diagnostic journey when dealing with new cognitive concerns. High-performance testing with our PrecivityAD2 blood test has the potential to provide clarity and shorten that diagnostic journey, while significantly elevating healthcare quality.”

NFL Alumni Joel Dreessen and Le-Lo Lang Team Up With HeartFlow and Boone Heart Institute to Launch GAMEFILM Registry to Assess Heart Disease Risks in Retired Football Players

The GAMEFILM Registry will enroll approximately 120 NFL alumni. The Registry will leverage coronary computed tomography angiography (CCTA) imaging and insights from the HeartFlow ONE platform (HeartFlow FFRCT and Plaque Analysis) to collect observational data with the goal of better understanding CAD prevalence, risk factors, severity, and treatment protocols among retired athletes.

Biotechnology News

Mainz Biomed and Liquid Biosciences Make Groundbreaking Discovery of mRNA Biomarkers for Blood Based Detection of Pancreatic Cancer

Guido Baechler, CEO of Mainz Biomed: “Securing the exclusive rights to license this portfolio of novel biomarkers is a major milestone and extension of our previously announced PancAlert program. It provides us with an extraordinary opportunity in the early detection and diagnosis of one of the most challenging cancers to treat. We believe that this achievement marks a paradigm shift in how we can detect pancreatic cancer.”

Medigene Submits Patent for Unique NK-Specific TCR Construct with European Patent Office

“This innovative approach supports our strategy to apply Medigene’s 3S TCRs into new TCR-guided modalities, such as TCR-TCEs and now TCR-NKs, to create additional value for both patients and our shareholders,” said Selwyn Ho, CEO of Medigene. “Expanding our TCR-guided therapies to include NK cells aligns with our commitment to developing off-the-shelf, highly specific, and effective immunotherapies for cancer treatment.”

COEPTIS’ NexGenAI Affiliates Partners with NUBURU Network to Drive Innovation in AI and Robotics as Part of its Transformation Plan

Dave Mehalick, CEO of COEPTIS stated, “Partnering with NUBURU marks a significant step in COEPTIS’ journey toward pioneering innovative technology solutions. By harnessing the power of NexGen’s AI-driven capabilities, we are poised to not only enhance our own operational efficiencies but also redefine how businesses engage with their clients in the rapidly evolving defense and security landscape. This collaboration underscores our commitment to fostering growth through advanced technological integrations.”

Our Experts – Byline Articles

Read Their Views & Share With a Colleague or Two!

FDA Medical Device Updates

Comprehensive Insights into Medical Device & Biotechnology Company Mergers, Acquisitions & Funding

MolecuLight Secures $11.7 Million in Financing to Accelerate Global Expansion

“MolecuLight’s innovative technology has the potential to significantly improve patient outcomes and offers compelling benefits for all healthcare system stakeholders,” said Guillermo Freire, Senior Vice-President, Mid-Market Group, EDC. “We are excited to invest in MolecuLight as they accelerate commercialization. EDC is focused on supporting emerging Canadian innovators in critical sectors essential for the future. This investment reflects our belief in innovation and progress, underscoring mission is to support Canadian companies in their journey to become international leaders in their sectors.”

Market Reports

Advancements in Imaging

KA Imaging Reports Record Revenue Plus Strategic Hires

KA Imaging reported a collection of positive metrics to its stakeholders, with revenue four times larger than that of the previous year and a 38% growth in headcount in 2023. The positive trend continues to be observed in Q1 2024.

Sectra

Sectra Reports Enterprise Imaging Solution Now Covers Majority of Midwest Patients Following New Contract

Isaac Zaworski, President of Sectra advises: “Collaborating across sites and providing efficient radiology workflows are needed to cope with the increasing imaging volumes. This new customer is the 60th healthcare provider to use Sectra in the US Midwest and I’m pleased to be continuing our work in this area. With our local experience as well as our knowledge in providing multi-site solutions for large organizations we will help them on this journey in the best way possible.”

Hospitals In the News

Medical Device and Biotechnology Executives: Innovative Professionals on the Move and Making Waves in the Industry

Non-Profit News

Healthcare - Understanding the Business Side of the Industry and Its Implications

Nanomedicine

Unlocking the Healing Power: The Importance of Nanomedicine

This article covers the place of nanomedicine in modern medicine and how it has altered treatments. Here we also discuss the importance of nanomedicine. Using substances at the nanoscale, like nanoparticles, for medicinal reasons is known as nanomedicine. 

Digital Solutions

Transforming Healthcare with Tailored Digital Solutions

Digital solutions: In the ever-changing landscape of healthcare, custom software solutions have emerged as game-changers, empowering healthcare organizations to achieve unparalleled efficiency, enhance patient experiences, and drive operational excellence. By tailoring digital tools to their unique needs, healthcare providers can streamline workflows, improve collaboration, ensure compliance, and ultimately deliver better outcomes for patients.

Telemedicine Business

Telemedicine Business – How to Setup and Stay Afloat

Telemedicine business is not as complicated as many people may think. It is all about taking advantage of the modern technology and incorporating it in the health sector. The most important thing is finding the right telemedicine business software, which you can get through a reliable developer.

Healthcare Careers

Nurses Corner

ER Nurses

Ten Coping Strategies for ER Nurses

ER nurses are on the frontline, dealing with life-threatening situations, high-stress environments, and a fast-paced work atmosphere. The constant exposure to critical cases can take a significant toll on their physical and emotional well-being. Therefore, it is essential for ER nurses to have effective coping strategies to manage the stress of the job, maintain their mental health, and provide the best care to their patients.

Majority of Medical and Nursing Students Planning Careers Outside Patient Care, as Fears of Burnout and Clinician Shortages Leave Them Worried about the Future

The report reveals how the challenges of being a frontline health professional in the US today are impacting the longer-term career decisions of students, highlighting increasingly challenging times ahead for an already overburdened healthcare system. Although almost 9 out of 10 medical and nursing students in the US feel devoted to improving patients’ lives, findings reveal that 58% already see their current studies as a steppingstone toward a broader career in healthcare that will not involve directly caring for patients.

Nursing shortage

Nursing is Officially America’s Dream Job | So why the Staffing Shortages?

In a study to find out America’s most desirable jobs, analysts at Business Name Generator found that nursing is the most in-demand career in the country. They analyzed over 22,000 search terms related to job seeking to identify the most-searched-for professions. Six of the top 20 most popular jobs are in the healthcare industry.

Health: A Comprehensive Exploration of Wellness, Nutrition, and Overall Well-Being for a Healthier Life

Articles Designed to Inspire and Guide You Toward Achieving Excellence and Success in All Your Endeavors.